Territorial Gains

Business

Brown & Brown Faces Talent Exodus and Legal Turmoil Amid Stock Slump

Insurance brokerage giant Brown & Brown is grappling with a significant talent drain to a rival, launching legal action to stem the flow, while also mourning the loss of its top lawyer. These challenges unfold against a backdrop of a sharply declining share price, raising questions about the firm's near-term stability and strategic direction.

Feb 3, 2026

Business

InSilico Medicine's 60% Surge: AI Hype or Justified Valuation?

InSilico Medicine Cayman TopCo's shares have rocketed over 60% in a month, forcing investors to scrutinize whether its AI-driven drug discovery promise can justify the momentum, especially against a backdrop of persistent losses and a negative book value.

Feb 3, 2026

Business

YouTube Cracks Down on AI-Generated Spam, Shutters Popular Channels in Push for Quality

YouTube has taken decisive action against a wave of AI-generated spam content, removing over a dozen popular channels. CEO Neal Mohan emphasizes the platform's commitment to combating deceptive practices as it seeks to protect its ecosystem for viewers and advertisers.

Feb 3, 2026

Business

The Great Wealth Transfer's Hidden Burden: Why Inheriting a Home Isn't a Simple Windfall

As trillions pass to heirs, inheriting property often brings complex financial obligations, from taxes to upkeep, that can erode perceived wealth gains. Experts urge careful planning to navigate the emotional and fiscal challenges.

Feb 2, 2026

Business

Hussman Strategic Advisors Exits Position in Biotech Firm TG Therapeutics

Investment firm Hussman Strategic Advisors has liquidated its entire stake in TG Therapeutics, a move that comes as the biotech's stock lags behind broader market gains despite reporting strong revenue growth for its flagship product.

Feb 2, 2026

World

Palantir CEO Defends Surveillance Tech Amid Soaring Government Sales, ICE Scrutiny

As Palantir Technologies reports a massive surge in U.S. government revenue, CEO Alex Karp publicly defends the company's controversial surveillance platforms, insisting they contain safeguards against overreach. The defense comes amidst growing public and political scrutiny over its contracts with immigration enforcement agencies.

Feb 2, 2026

Business

Insider Bets in Asia's Small-Cap Arena: Three Undervalued Stocks to Watch in February 2026

Amidst a backdrop of economic crosscurrents, savvy investors are tracking insider moves within Asia's small-cap sector for clues on potential value. We examine three companies where recent executive share purchases signal confidence against the odds.

Feb 2, 2026

Business

O'Reilly Automotive's Stellar Run: Is the Auto Parts Giant Now Overvalued?

O'Reilly Automotive shares have delivered impressive multi-year gains, but a deep dive into valuation metrics suggests the stock may now be trading at a significant premium. We analyze the numbers and what they mean for investors considering a position.

Feb 2, 2026

Business

The Great Rotation: Investors Shift from Equities to Bonds After Historic Bull Run

As stock markets cool from years of stellar gains, a disciplined rebalancing is underway. Vanguard data reveals a broad-based move into fixed income, signaling a strategic pivot rather than panic.

Feb 2, 2026

Business

VEON's Meteoric Rise: Is the Telecom Stock Still a Bargain After Tripling in Three Years?

VEON's shares have surged over 340% in three years, dramatically outperforming the market. As the stock hovers around $54, analysts are divided: does this represent a classic value opportunity or a sign that the easy gains are over? We examine the valuation metrics behind the headline numbers.

Feb 2, 2026

Business

Universal Pulls CFO Offer from ADM Executive Amid SEC Accounting Scandal

Universal has rescinded its employment offer to a former ADM finance executive just one day after the SEC filed suit against ADM's ex-CFO over alleged accounting misconduct in the nutrition segment, highlighting the widening fallout from the agribusiness giant's regulatory troubles.

Feb 2, 2026

Business

Palantir's Surveillance Tech Faces Scrutiny as Government Contracts Fuel Record Growth

Amid surging government revenue and public protests over its ICE contracts, Palantir CEO Alex Karp defends the company's controversial surveillance technology, framing it as a safeguard against state overreach rather than an enabler.

Feb 2, 2026

Business

Wheat Futures Extend Losses Amid Dollar Strength, Mixed Export Signals

U.S. wheat futures fell across the board on Monday, pressured by a stronger dollar and a weekly decline in export inspections, despite year-over-year shipment gains and managed money trimming short positions.

Feb 2, 2026

US

Alabama Mother and Two Children Feared Forcibly Taken from Home, Police Cite Signs of Struggle

Authorities in Mobile County are urgently searching for a missing mother, her teenage daughter, and toddler son after discovering evidence of a disturbance at their residence, indicating they may have been taken against their will.

Feb 2, 2026

Business

AMD's Q4 Earnings in Focus: AI Spending Scrutiny Meets High-Stakes Product Ambitions

As AMD prepares to release its fourth-quarter results, the chipmaker finds itself at a critical juncture, balancing Wall Street's anxiety over AI infrastructure costs against its aggressive push to challenge Nvidia's dominance with new data center and PC products.

Feb 2, 2026

Business

Jim Cramer Touts Rio Tinto as a 'Haven' Amid Global Uncertainty

CNBC's Jim Cramer reaffirmed his bullish stance on Rio Tinto, highlighting the mining giant's role as a strategic hedge against geopolitical and economic volatility during the show's Lightning Round.

Feb 2, 2026

Business

Cramer Cools on Novo Nordisk: 'It's a Hold, Not a Buy' After Stellar Run

CNBC's Jim Cramer tempered enthusiasm for Novo Nordisk stock, suggesting investors hold rather than buy after its massive gains driven by blockbuster weight-loss drugs.

Feb 2, 2026

Business

AbbVie's Valuation Crossroads: Short-Term Volatility Meets Long-Term Strength

AbbVie's stock presents a complex picture for investors, with recent mixed performance contrasting sharply with its robust multi-year returns. As shares trade below consensus targets, the market weighs near-term headwinds against the pharmaceutical giant's proven track record and pipeline potential.

Feb 2, 2026

Business

Amazon in Talks for Massive $50 Billion OpenAI Stake Amid AI-Driven Restructuring

Amazon is reportedly negotiating a landmark investment of up to $50 billion in OpenAI, a move that would cement its position as a dominant AI investor. The talks coincide with a wave of layoffs—reportedly around 30,000 since October—that management has linked to efficiency gains from automation, raising questions about the balance between AI ambition and workforce impact.

Feb 2, 2026

World

Amid Rising Tensions, U.S. Air Drills in Middle East Signal Military Posture as Trump Warns Iran

The United States is conducting multi-day air force exercises in the Middle East, showcasing rapid deployment capabilities, as former President Donald Trump renews threats of military action against Iran unless it returns to nuclear negotiations. The drills occur against a backdrop of heightened rhetoric and regional unease.

Feb 2, 2026